Milvexian
Milvexian is a pharmaceutical drug with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants
A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants
Clinical Trials (7)
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants
A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants
A Study of Milvexian in Healthy Adult Females
A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7